Mckesson (MCK) Non-Current Deferred Tax Liability (2010 - 2026)
Mckesson's (MCK) quarterly Non-Current Deferred Tax Liability came in at $2.8 billion in Q1 2026, up 5.56% year-on-year from $2.6 billion in Q1 2025, and up 150.27% on a QoQ basis from $1.1 billion in Q4 2025.
Mckesson (MCK) Non-Current Deferred Tax Liability (2010 - 2026) Analysis & Trends
Mckesson (MCK) has 17 years of Non-Current Deferred Tax Liability data on file, last reported at $2.8 billion in Q1 2026.
- On a quarterly basis, Non-Current Deferred Tax Liability rose 5.56% year-over-year to $2.8 billion in Q1 2026; TTM through Mar 2026 was $2.8 billion, a 5.56% increase from a year earlier, with the FY2026 full-year figure at $2.8 billion, up 5.56% from the prior year.
- Non-Current Deferred Tax Liability for Q1 2026 stood at $2.8 billion, up from $1.1 billion in the prior quarter.
- Over the last five years, Non-Current Deferred Tax Liability for MCK reached as high as $2.8 billion in Q1 2022 and fell as low as $928.0 million in Q2 2024.
- Historically, Non-Current Deferred Tax Liability has averaged $1.5 billion across 5 years, with a median of $1.1 billion in 2023.
- Across the five-year window, Non-Current Deferred Tax Liability slumped 50.95% in 2023 and soared 83.78% in 2024, its largest moves.
- Year by year, Non-Current Deferred Tax Liability stood at $1.5 billion in 2022, then tumbled by 33.24% to $978.0 million in 2023, then gained by 11.66% to $1.1 billion in 2024, then grew by 1.47% to $1.1 billion in 2025, then jumped by 150.27% to $2.8 billion in 2026.
- Per Business Quant data, the three most recent Non-Current Deferred Tax Liability figures were $2.8 billion in Q1 2026, $1.1 billion in Q4 2025, and $1.1 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Mckesson | 105.15 Bn | 101.18 Bn | 4.04 Bn |
| 2 | Cencora | 60.58 Bn | 58.40 Bn | 3.59 Bn |
| 3 | Cardinal Health | 53.81 Bn | 49.87 Bn | 2.50 Bn |
| 4 | Henry Schein | 9.71 Bn | 9.57 Bn | 1.07 Bn |
| 5 | Akso Health | 3.28 Bn | 3.28 Bn | - |
| 6 | 111 | 651.73 Mn | 572.63 Mn | 23.58 Mn |
| 7 | Accendra Health | 248.02 Mn | -88.86 Mn | 278.03 Mn |
| 8 | Edap Tms | 230.14 Mn | 215.14 Mn | 8.15 Mn |
| 9 | VitaNova Life Sciences | 11.51 Mn | 11.01 Mn | 316,343.00 |
| 10 | Cosmos Health | 9.57 Mn | 7.41 Mn | 1.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.77 Bn |
| Mar 31, 2026 | 2.77 Bn |
| Dec 31, 2025 | 1.11 Bn |
| Dec 31, 2025 | 1.11 Bn |
| Sep 30, 2025 | 1.09 Bn |
| Sep 30, 2025 | 1.09 Bn |
| Jun 30, 2025 | 987.00 Mn |
| Jun 30, 2025 | 987.00 Mn |
| Mar 31, 2025 | 2.63 Bn |
| Mar 31, 2025 | 2.63 Bn |
| Dec 31, 2024 | 1.09 Bn |
| Dec 31, 2024 | 1.09 Bn |
| Sep 30, 2024 | 1.05 Bn |
| Sep 30, 2024 | 1.05 Bn |
| Jun 30, 2024 | 928.00 Mn |
| Jun 30, 2024 | 928.00 Mn |
| Mar 31, 2024 | 2.55 Bn |
| Mar 31, 2024 | 2.55 Bn |
| Dec 31, 2023 | 978.00 Mn |
| Dec 31, 2023 | 978.00 Mn |